Two Sigma Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,782
Closed -$277K 2419
2024
Q2
$277K Buy
+6,782
New +$277K ﹤0.01% 792